Nasdaq
$12.37▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $511.1MShares out 41.3M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
32- 10.8Regular26.10.09 01:5610-QEarnings#●●●#●●●
ANGIODYNAMICS INC
AngioDynamics reported net sales of $80.915 million for the first quarter of fiscal year 2026, up from $75.711 million in the same period last year. The company recorded a net loss of $7.097 million, an improvement from the $10.903 million net loss reported in the prior year's quarter.…more
$12.37+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.8Regular26.10.08 23:25DEFA14AOther
ANGIODYNAMICS INC
AngioDynamics, Inc. has filed additional definitive proxy materials (DEFA14A) regarding its upcoming shareholder meeting. This filing provides procedural information for voting and does not contain any updates regarding the company's financial status or capital structure.…more
$12.37+0.00%vs prev closeView filingShare - 10.8Pre-market26.10.08 21:16DEF 14AOther
ANGIODYNAMICS INC
AngioDynamics will hold its annual meeting of shareholders on November 17, 2026, to vote on director elections, auditor ratification, executive compensation, and an amendment to the 2020 Equity Incentive Plan. For the fiscal year ended May 31, 2026, the company reported a 9.5% increase in total revenue, driven by 18.4% growth in the Med Tech segment and 2.6% growth in the Med Device segment.…more
$12.37+0.00%vs prev closeView filingShare
31 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 4d agoPre-market26.10.21 21:43Bullish#●●●#●●●
AngioDynamics Reports Positive Pancreatic Cancer Study Results and New CPT Code…more
AngioDynamics announced that its IRE-based treatment strategy demonstrated improved overall survival in Stage III pancreatic cancer patients. Additionally, the company secured a new Category I CPT code for open pancreatic IRE ablation, effective January 1, 2027.…more
$12.37+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 10.14Pre-market26.10.14 20:06
●●●●●●●● ●●●●● ●●●●●●
Humana has updated its Medicare Advantage policy to cover the NanoKnife system for eligible prostate and liver cancer patients starting October 1. This coverage expansion is expected to improve patient access and potentially boost the company's revenue.…more
$12.37+0.00%vs prev closeShareBenzinga - 10.8Regular26.10.09 02:44
●●●●●●●● ●●●●● ●●●●●●
AngioDynamics shares fell over 21% despite reporting first-quarter financial results that exceeded analyst expectations and announcing a new CEO. While the company reaffirmed its fiscal 2027 guidance and received FDA approval for a new study, the stock faced significant selling pressure.…more
$12.37+0.00%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report